Axogen AXGN
NASDAQ AXGN
$47.27 +0.58 (+1.24%)
As of: Sep 9, 2026 · 3:59 PM EDT

Axogen (AXGN) Net Income towards Common Stockholders (2010 - 2026)

Axogen (AXGN) posted Net Income towards Common Stockholders of -$1.4 million for Q2 2026, up 50.29% on a QoQ basis from -$2.8 million in Q1 2026, and down 1613.75% year-over-year from $90569.8 in Q2 2025.

Analysis

Axogen (AXGN) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Axogen has reported Net Income towards Common Stockholders for 17 years, with the latest figure at -$1.4 million in Q2 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 1613.75% year-over-year to -$1.4 million in Q2 2026; TTM through Jun 2026 was -$14.8 million, a 190.57% decrease from a year earlier, with the FY2025 full-year figure at -$14.4 million, down 38.94% from the prior year.
  • Net Income towards Common Stockholders was -$1.4 million for Q2 2026 at Axogen, up from -$2.8 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $541000.0 in Q4 2024, with the low at -$11.7 million in Q1 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$4.5 million, with a median of -$4.6 million recorded in 2023.
  • The largest YoY upside for Net Income towards Common Stockholders was 124.78% in 2025 against a maximum downside of 2158.78% in 2025.
  • Over 5 years, Net Income towards Common Stockholders stood at -$5.2 million in 2022, then increased by 9.09% to -$4.7 million in 2023, then surged by 111.51% to $541000.0 in 2024, then sank by 2158.78% to -$11.1 million in 2025, then soared by 87.69% to -$1.4 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$1.4 million (Q2 2026), -$2.8 million (Q1 2026), and -$11.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 1.48 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 907.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 249.10 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 201.00 Mn
10 Axogen 2.51 Bn 2.40 Bn 50.67 Mn -1.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.37 Mn
Mar 31, 2026 -2.76 Mn
Dec 31, 2025 -11.14 Mn
Sep 30, 2025 474,000.00
Jun 30, 2025 -80,000.00
Mar 31, 2025 -3.64 Mn
Dec 31, 2024 541,000.00
Sep 30, 2024 -1.91 Mn
Jun 30, 2024 -2.39 Mn
Mar 31, 2024 -6.59 Mn
Dec 31, 2023 -4.70 Mn
Sep 30, 2023 -4.49 Mn
Jun 30, 2023 -6.82 Mn
Mar 31, 2023 -6.81 Mn
Dec 31, 2022 -5.17 Mn
Sep 30, 2022 -4.73 Mn
Jun 30, 2022 -8.14 Mn
Mar 31, 2022 -11.72 Mn
Dec 31, 2021 -5.27 Mn
Sep 30, 2021 -7.09 Mn